Maxor Selected as Limited Distribution Provider of Orkambi® and Kalydeco®

Maxor National Pharmacy Services, LLC (“Maxor”), today announced that Vertex Pharmaceuticals Inc. has now included Maxor Specialty, comprised of IV Solutions and Pharmaceutical Specialties (“PSI”), in its specialty pharmacy network. Effectively immediately, patients may now utilize Maxor Specialty for Orkambi® and Kalydeco®, two leading medications used in the treatment of certain types of Cystic Fibrosis (“CF”).  

Rare Disease Day 2017

Rare Disease Day, launched in Europe in 2008, is held the last day of February every year and seeks to raise awareness of the impact that rare or orphan diseases have on the lives of patients and those who care for them.  The USA joined the campaign in 2009 and over 80 countries throughout the world participated in 2016. The theme for 2017 is “RESEARCH” and the slogan is “With research, possibilities are limitless.”

Maxor Announces New CEO

AMARILLO, TX – Maxor National Pharmacy Services, LLC (“Maxor” or the “Company”), a leading pharmacy services platform, today announced the retirement of John Ward, CEO of Maxor effective April 4. In October 2015, Mr. Ward had indicated his intention to retire by the end of 2016. He will remain on the Board of Directors and a significant investor in the Company.

Prescription Drugs Are Scary

Prescription drug costs are scary. With the industry trends and issues with generic prices, clients continue seeing their drug spend increase each year. How do you combat this? Read more to see the MaxorPlus solution, as written by Jen Kirsch, Regional Sales Director, MaxorPlus.


Yes, yes they are. Compounds, specialty drugs, and price increases … oh my!

Prescription drugs have been in the news non-stop for the past several weeks. Headlines include:

Subscribe to RSS - blogs